Pilotstudie: Anti-IL36-Antikörper Spesolimab bei pustulöser palmoplantarer Psoriasis • MedWiss.Online

Original Titel:
Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind,…